| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Chemical Name: | REBAMIPIDE |
| Molecular Formula: | C19H15ClN2O4 |
| Formula Weight: | 370.79 |
| CAS No.: | 90098-04-7 |
Rebamipide, also known as rebapide, is a new type of anti-ulcer drug. In 1990, it was first marketed in Japan as a drug for gastric ulcer and acute and chronic gastritis. Rebamipide is a gastric mucosal protectant, which can increase the blood flow of gastric mucosa, the synthesis of prostagland E2 and gastric mucus secretion.
It can promote the expression of epidermal grow factor and its receptor Chemicalbook, prevent ulcer and promote ulcer healing.
Studies have shown that it is effective for various experimental gastric ulcers, can promote the production of prostagland in gastric mucosa, protect gastric mucosa from the harm of various ulcer-causing factors, suitable for the treatment of gastric ulcers, acute gastritis, acute aggravation of chronic gastritis, gastric mucosa lesions, has a high clinical value.
){kind=link}